Chris Freeman - Mar 15, 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Commercial Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Chris Freeman
Stock symbol
GH
Transactions as of
Mar 15, 2025
Transactions value $
-$16,598
Form type
4
Date filed
3/18/2025, 05:26 PM
Previous filing
Mar 13, 2025
Next filing
Apr 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +1.4K +3.61% $0.00 40.2K Mar 15, 2025 Direct
transaction GH Common Stock Tax liability -$16.6K -387 -0.96% $42.89 39.8K Mar 15, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -1.4K -16.66% $0.00 7.01K Mar 15, 2025 Common Stock 1.4K $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
F3 Not applicable for Restricted Stock Units.